FDA Issues Warning Over Paclitaxel-Coated Balloons, Stents

Drug Industry Daily
A A
The FDA issued an updated alert based on a “potentially concerning signal” that the chemotherapy drug paclitaxel on balloons and stents might be contributing to patient deaths.

To View This Article:

Login

Subscribe To Drug Industry Daily